Cargando…
Reasons Why Combination Therapy Should Be the New Standard of Care to Achieve the LDL-Cholesterol Targets: Lipid-lowering combination therapy
PURPOSE OF REVIEW: The aim of this report is to review the scientific evidence supporting that lipid lowering therapy (LLT), beyond statins, reduces cardiovascular risk; therefore, treatment strategies based on lipid-lowering drug combination should be implemented. RECENT FINDINGS: A strong scientif...
Autores principales: | Masana, Lluís, Ibarretxe, Daiana, Plana, Núria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305062/ https://www.ncbi.nlm.nih.gov/pubmed/32562015 http://dx.doi.org/10.1007/s11886-020-01326-w |
Ejemplares similares
-
Achievement of low-density lipoprotein cholesterol goals in 18
countries outside Western Europe: The International ChoLesterol management
Practice Study (ICLPS)
por: Danchin, Nicolas, et al.
Publicado: (2018) -
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries
Publicado: (2020) -
Prion Infection Impairs Cholesterol Metabolism in Neuronal Cells
por: Cui, Huanhuan L., et al.
Publicado: (2014) -
Sphingolipid Domains in the Plasma Membranes of Fibroblasts Are Not Enriched with Cholesterol
por: Frisz, Jessica F., et al.
Publicado: (2013) -
Effects of a Disrupted Blood-Brain Barrier on Cholesterol Homeostasis in the Brain
por: Saeed, Ahmed A., et al.
Publicado: (2014)